UPMC Imaging Services at Lititz and Lancaster have been designated as Centers of Excellence (COEs) by GO2 for Lung Cancer for their commitment to provide the Lancaster community with patient-centered, evidence-based lung cancer screenings.

COEs designated in lung cancer screening are committed to facilitating patient-centered communication and decision-making. COEs implement screening that is in accordance with current evidence and clinical guidelines from organizations such as the American College of Radiology (ACR) and the National Comprehensive Cancer Network (NCCN) while using a multidisciplinary approach to coordinate follow-up care, diagnostics, and treatment. While the recognition highlights the imaging services in Lititz and Lancaster, UPMC has lung cancer screening COE designation across the central Pennsylvania region.

Lung cancer has been the long-leading cause of cancer deaths in the United States, and most lung cancer diagnoses are made at the advanced stage of the disease. By providing individuals at high risk with screening that uses low-dose computed tomography, lung cancer can be found early when it is more treatable and potentially curable.